Your browser doesn't support javascript.
loading
Application of nano-radiosensitizers in combination cancer therapy.
Varzandeh, Mohammad; Sabouri, Leila; Mansouri, Vahid; Gharibshahian, Maliheh; Beheshtizadeh, Nima; Hamblin, Michael R; Rezaei, Nima.
Afiliação
  • Varzandeh M; Department of Materials Engineering Isfahan University of Technology Isfahan Iran.
  • Sabouri L; AmitisGen TECH Dev Group Tehran Iran.
  • Mansouri V; Regenerative Medicine Group (REMED) Universal Scientific Education and Research Network (USERN) Tehran Iran.
  • Gharibshahian M; Regenerative Medicine Group (REMED) Universal Scientific Education and Research Network (USERN) Tehran Iran.
  • Beheshtizadeh N; Gene Therapy Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences Tehran Iran.
  • Hamblin MR; Regenerative Medicine Group (REMED) Universal Scientific Education and Research Network (USERN) Tehran Iran.
  • Rezaei N; Student Research Committee School of Medicine, Shahroud University of Medical Sciences Shahroud Iran.
Bioeng Transl Med ; 8(3): e10498, 2023 May.
Article em En | MEDLINE | ID: mdl-37206240
ABSTRACT
Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation-induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano-radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article